Abstract:Encapsulation devices are an emerging barrier technology designed to prevent the immunorejection of replacement cells in regenerative therapies for intractable diseases. However, traditional polymers used in current devices are poor substrates for cell attachment and induce fibrosis upon implantation, impacting long-term therapeutic cell viability. Bioactivation of polymer surfaces improves local host responses to materials, and here we make the first step toward demonstrating the utility of this approach to improve cell survival within encapsulation implants. Using therapeutic islet cells as an exemplar cell therapy, we show that internal surface coatings improve islet cell attachment and viability, while distinct external coatings modulate local foreign body responses. Using plasma surface functionalization (plasma immersion ion implantation (PIII)), we employ hollow fiber semiporous poly(ether sulfone) (PES) encapsulation membranes and coat the internal surfaces with the extracellular matrix protein fibronectin (FN) to enhance islet cell attachment. Separately, the external fiber surface is coated with the anti-inflammatory cytokine interleukin-4 (IL-4) to polarize local macrophages to an M2 (anti-inflammatory) phenotype, muting the fibrotic response. To demonstrate the power of our approach, bioluminescent murine islet cells were loaded into dual FN/IL-4-coated fibers and evaluated in a mouse back model for 14 days. Dual FN/IL-4 fibers showed striking reductions in immune cell accumulation and elevated levels of the M2 macrophage phenotype, consistent with the suppression of fibrotic encapsulation and enhanced angiogenesis. These changes led to markedly enhanced islet cell survival and importantly to functional integration of the implant with the host vasculature. Dual FN/IL-4 surface coatings drive multifaceted improvements in islet cell survival and function, with significant implications for improving clinical translation of therapeutic cell-containing macroencapsulation implants.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c20096?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c20096</a>.Surface chemistry analysis of PES fibers following PIII treatment (Figure S1); in vitro validation of external IL-4 coating bioactivity using qPCR analysis of RAW 264.7 macrophages of classical M2 phenotype genes (Figure S2); in vitro comparison of whole islets vs dispersed islets/cells on treated PES (Figure S3); in vivo analysis of local immunomodulatory effects and comprehensive analysis of the nature of the immune microenvironment (Figure S4); and in vivo analysis of local angiogenesis (Figure S5) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c20096/suppl_file/am0c20096_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Toll-like receptor 2-modulating pectin-polymers in alginate-based microcapsules attenuate immune responses and support islet-xenograft survival

Zwitterionically Modified Alginates Mitigate Cellular Overgrowth for Cell Encapsulation

Alginate–Poly [2-(methacryloyloxy)ethyl]trimethylammonium Chloride (PMETAC) Immunoisolating Capsules Prolong the Viability of Pancreatic Islets In Vivo

Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol

Probing of New Polymer-Based Microcapsules for Islet Cell Immunoisolation

Allotransplantation of sulphate glucomannan-alginate barium (SGA)-microencapsulated rat islets for the treatment of diabetes mellitus.

Suppression of Fibrotic Reactions of Chitosan-Alginate Microcapsules Containing Porcine Islets by Dexamethasone Surface Coating

This paper is a winner in the Undergraduate category for the SFB awards: Evaluation of the tissue response to alginate encapsulated islets in an omentum pouch model

Biocompatibility of purified sodium alginate-barium chloride microcapsule and functional assessment of transplanted pancreas islet via the microcapsule for type Ⅰ diabetes

ECM-based bioactive microencapsulation significantly improves islet function and graft performance

Immunological Challenges Facing Translation of Alginate Encapsulated Porcine Islet Xenotransplantation to Human Clinical Trials

Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug.

Encapsulation of porcine pancreatic islets within an immunoprotective capsule comprising methacrylated glycol chitosan and alginate

Exosome loaded immunomodulatory biomaterials alleviate local immune response in immunocompetent diabetic mice post islet xenotransplantation

Short-term function and immune-protection of microencapsulated adult porcine islets with alginate incorporating CXCL12 in healthy and diabetic non-human primates without systemic immune suppression: A pilot study

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Dual Crosslinking of Alginate Outer Layer Increases Stability of Encapsulation System

The relationship between the inflammatory response and cell adhesion on alginate-chitosan-alginate microcapsules after transplantation.

Bioactivation of Encapsulation Membranes Reduces Fibrosis and Enhances Cell Survival

Microfluidic Production of Zwitterion Coating Microcapsules with Low Foreign Body Reactions for Improved Islet Transplantation

Xenotransplantation of alginate-chitosan-polyethyleneglycol microencapsulated rat islets in the treatment of mice diabetes mellitus. Preliminary data and future perspective